Churchill Management Corp Abb Vie Inc. Transaction History

Churchill Management Corp

$8.64 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $314,815 - $362,557	2,177 Added 2.74%	81,731 $13 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $37,620 - $45,116	-272 Reduced 0.34%	79,554 $12.9 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $259,469 - $311,172	1,876 Added 2.41%	79,826 $12.9 Million
Q3 2022 Oct 11, 2022	BUY	$134.21 - $153.93 $3.83 Million - $4.39 Million	28,530 Added 57.73%	77,950 $10.5 Million
Q2 2022 Jul 08, 2022	BUY	$137.62 - $174.96 $878,703 - $1.12 Million	6,385 Added 14.84%	49,420 $7.57 Million
Q1 2022 Apr 12, 2022	BUY	$131.98 - $163.75 $464,041 - $575,745	3,516 Added 8.9%	43,035 $6.98 Million
Q4 2021 Jan 11, 2022	SELL	$107.43 - $135.93 $74,448 - $94,199	-693 Reduced 1.72%	39,519 $5.35 Million
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Reduced 0.49%	40,212 $4.34 Million
Q2 2021 Jul 08, 2021	SELL	$105.21 - $117.21 $144,874 - $161,398	-1,377 Reduced 3.3%	40,412 $4.55 Million
Q1 2021 Apr 08, 2021	SELL	$102.3 - $112.62 $13.1 Million - $14.4 Million	-128,098 Reduced 75.4%	41,789 $4.52 Million
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $553,690 - $747,540	-6,879 Reduced 3.89%	169,887 $18.2 Million
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $113,143 - $132,793	-1,317 Reduced 0.74%	176,766 $15.5 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $189,441 - $253,500	2,582 Added 1.47%	178,083 $17.5 Million
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $2.02 Million - $3.06 Million	31,244 Added 21.66%	175,501 $13.4 Million
Q4 2019 Jan 22, 2020	BUY	$72.13 - $90.25 $10.4 Million - $13 Million	144,257 New	144,257 $12.8 Million
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $9.85 Million - $12.1 Million	-126,531 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$88.91 - $98.84 $11.2 Million - $12.5 Million	126,531 New	126,531 $12 Million
Q2 2018 Jul 10, 2018	SELL	$89.78 - $106.23 $22.3 Million - $26.4 Million	-248,704 Closed	0 $0
Q1 2018 Apr 13, 2018	SELL	$92.01 - $123.21 $1.27 Million - $1.7 Million	-13,833 Reduced 5.27%	248,704 $23.5 Million
Q4 2017 Jan 11, 2018	SELL	$89.56 - $98.21 $605,336 - $663,801	-6,759 Reduced 2.51%	262,537 $25.4 Million
Q3 2017 Oct 10, 2017	BUY	$69.85 - $89.22 $18.8 Million - $24 Million	269,296	269,296 $23.9 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Churchill Management Corp with notifications on news.

Account